News & Blog

News & Blog

  • Reset
News | Sep 11 2024

Stealth BioTherapeutics Awarded Grant from Friedreich’s Ataxia Research Alliance and FARA Ireland to Develop Investigational Mitochondrial Therapeutic SBT-589 for Friedreich’s Ataxia

FARA News | Industry News | Research
News | Sep 10 2024

Meet the 2024 FARA Fellows

The FARA Fellow Program recognizes young investigators who will commit their early career to FA research and want to grow their profile ...

FARA News | Research
News | Sep 4 2024

FA Community Conversations Genetic Therapies Webinar: Recording Available on YouTube

Education
News | Aug 27 2024

FARA Celebrates 16 Years of Funding Adaptive Cycling Equipment Through The Ataxian Athlete Initiative (AAI) 

rideATAXIA
News | Aug 22 2024

United Against Ataxia Hill Day 2024 – Registration open!

Advocacy | FARA News
News | Aug 19 2024

August 2024 – Advocacy Newsletter

Advocacy
News | Aug 14 2024

Join us for FA Community Conversations – Genetic Medicine on August 29, 2024

Education
News | Aug 7 2024

Larimar Therapeutics Reports Several Updates on Nomlabofusp FA Program in Q2 2024 Operating and Financial Results

Industry News
News | Jul 23 2024

Job Opening – Accounting Specialist

FARA News
News | Jul 16 2024

FARA Advocates for Effective Inclusion of Children Early in Clinical Trials at Pediatric Inclusion Roundtable

Advocacy | FARA News
News | Jul 16 2024

2023 Donor Impact Report

FARA News
News | Jul 15 2024

LEXEO Therapeutics Announces Positive Interim Phase 1/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy

Industry News